Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Prolexys Pharmaceuticals, Inc.

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company’s therapeutic focus is on cancer and cardiovascular indications where Prolexys has identified novel, druggable therapeutic targets. Small molecules that act at these targets have been identified and tested in cell and animal models of disease. Lead programs include a) PRLX82845, a compound with selective anti-tumor activity, b) PRLX8025, a compound for colon cancer, c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation


Contact Details:
2150 West Dauntless Avenue (1000 North)
Salt Lake City
Utah
84116
United States of America
Tel:(801) 303-1700
Fax:(801) 303-1701
Email:info@prolexys.com
WWW:

www.prolexys.com/




Loading...

Press Releases on Prolexys Pharmaceuticals, Inc.:

BioPortfolio Logo
Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans. 13th March, 2009 Prolexys Pharmaceuticals, Inc.
SALT LAKE CITY, March 13 /PRNewswire/ -- Prolexys Pharmaceuticals announced today the publication of the discovery of genes that are likely to have a role in the aging process of humans. The findings

BioNews Results for Prolexys Pharmaceuticals, Inc.:

Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
Pharma Live:  Nov 23 2009 2:24AM Matching: pharmaceuticals inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.
Individual.com:  Nov 21 2009 6:41AM Matching: pharmaceuticals inc
Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
RBC Dain Rauscher:  Nov 21 2009 12:46AM Matching: pharmaceuticals inc
FDA approves sNDA for pediatric autism drug ABILIFY
News-Medical.Net:  Nov 21 2009 4:57AM Matching: pharmaceuticals inc
Global market for anti-depressants on a decline
News-Medical.Net:  Nov 20 2009 11:09AM Matching: pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Prolexys Pharmaceuticals, Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 273 times since April 2007, the link to the organisation's website has been followed 51 times

Search for more companies in Salt Lake City

Search for more companies in Utah



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Prolexys Pharmaceuticals, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.